Anti-Inflammatory and Antinociceptive Properties of the Quercetin-3-Oleate AV2, a Novel FFAR1 Partial Agonist
Authors:
- Federica PessinaFPFederica Pessina
- Ilenia CasiniICIlenia Casini
- Alessandra GamberucciAlessandra Gamberucci
- Gabriele CarulloGabriele Carullo
- Cinzia SignoriniCinzia Signorini
- Antonella BrizziABAntonella Brizzi
- Francesca AielloFrancesca Aiello
- Anna Maria AloisiAAAnna Maria Aloisi
- Stefano PierettiSPStefano Pieretti
Open Access
- 30 October 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (21) , 11635
Abstract
Free fatty acid receptor 1 (FFAR1) has emerged as the most targeted isoform of the free fatty acid receptors because of its involvement in the modulation of energy balance and its potential role in the control of inflammatory and pain conditions. Quercetin-3-oleate (AV2), recognized as a new FFAR1 partial agonist, was investigated for its ability to modulate inflammation and nociception. Human immortal neuroblastoma SH and the murine macrophagic RAW 264.7 cells were used to evaluate cell viability, the potential cytoprotective activity, and the anti-inflammatory properties of AV2 in vitro. Paw edema, caused by zymosan-A, and the formalin test were used to assess the in vivo anti-inflammatory and antinociceptive effects in CD-1 mice. In vitro, AV2 was devoid of cytotoxicity, significantly reduced ROS in both cell types, and protected RAW 264.7 cells from lipopolysaccharide damage by reducing tumor necrosis factor-α production. Interestingly, AV2 induced a transient elevation of intracellular calcium that was reduced in cells, pre-incubated with the FFAR1 antagonist DC260126. In vivo, AV2 reduced formalin-induced nociception and zymosan A-induced paw edema, and both effects were reversed by the FFAR1 antagonist GW1100. In conclusion, these data strongly support the AV2-mediated antioxidant, anti-inflammatory, and antinociceptive activity. AV2 represents a promising molecule for the clinical management of inflammatory-related pain conditions.Keywords
Funding Information
- Istituto Superiore di Sanità
- PSR, Università di Siena, Italy
This publication has 49 references indexed in Scilit:
- Methyl gallate attenuates inflammation induced by Toll-like receptor ligands by inhibiting MAPK and NF-Κb signaling pathwaysInflammation Research, 2020
- The involvement of free fatty acid-GPR40/FFAR1 signaling in chronic social defeat stress-induced pain prolongation in C57BL/6J male micePsychopharmacology, 2018
- Lauric Acid Alleviates Neuroinflammatory Responses by Activated Microglia: Involvement of the GPR40-Dependent PathwayNeurochemical Research, 2018
- Neuronal‐like differentiated SH‐SY5Y cells adaptation to a mild and transient H2O2‐induced oxidative stressCell Biochemistry and Function, 2018
- Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing ChallengesMedicinal Research Reviews, 2017
- Fasiglifam (TAK‐875) has dual potentiating mechanisms via Gαq‐GPR40/FFAR1 signaling branches on glucose‐dependent insulin secretionPharmacology Research & Perspectives, 2016
- Neuroprotective Effects ofCastanea sativaMill. Bark Extract in Human Neuroblastoma Cells Subjected to Oxidative StressJournal of Cellular Biochemistry, 2015
- Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysisArchives of Medical Research, 2012
- Bioactive Eicosanoids: Role of Prostaglandin F2α and F2-Isoprostanes in Inflammation and Oxidative Stress Related PathologyMolecules and Cells, 2010
- Pharmacological studies on zymosan inflammation in rats and mice. 1: Zymosan-induced paw oedema in rats and micePharmacological Research, 1989